Cryoport, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $176.2M | $156.8M | $168.7M | $237.3M | $222.6M |
| Cost of revenue | $93.1M | $87.1M | $93.3M | $133.4M | $126.0M |
| Gross profit | $83.1M | $69.7M | $75.3M | $103.9M | $96.6M |
| Selling, general & administrative | $102.8M | $109.8M | $108.3M | $120.1M | $97.6M |
| Research and development | $17.0M | $17.7M | $18.0M | $15.7M | $16.8M |
| Operating expenses | $119.9M | $191.3M | $175.9M | $135.8M | $114.4M |
| Operating income | -$36.8M | -$121.7M | -$100.5M | -$31.9M | -$17.8M |
| Interest expense | $2.4M | $4.0M | $5.5M | $6.1M | $4.7M |
| Pretax income | -$32.2M | -$104.3M | -$84.2M | -$35.1M | -$273.8M |
| Income tax expense | $1.8M | $359,000 | $345,000 | $2.2M | $1.7M |
| Net income | $78.3M | -$114.8M | -$99.6M | -$37.3M | -$275.5M |
| Balance Sheet | |||||
| Cash and equivalents | $250.5M | $34.1M | $35.2M | $29.2M | $139.1M |
| Current assets | $476.2M | $341.6M | $535.1M | $604.2M | $693.5M |
| Total assets | $765.0M | $703.5M | $957.7M | $1.0B | $1.1B |
| Current liabilities | $219.0M | $64.6M | $45.6M | $40.9M | $42.6M |
| Total liabilities | $262.4M | $301.6M | $468.7M | $482.9M | $471.1M |
| Stockholders' equity | $502.6M | $401.9M | $489.0M | $555.8M | $641.8M |
| Cash Flow Statement | |||||
| Cash from operations | -$8.6M | -$16.3M | -$757,000 | -$1.9M | $8.1M |
| Depreciation and amortization | $27.7M | $30.8M | $27.5M | $22.8M | $20.2M |
| Stock-based compensation | $10.1M | $16.6M | $19.8M | $20.1M | $15.3M |
| Capital expenditure | $16.4M | $17.3M | $38.8M | $22.1M | $23.9M |
| Free cash flow | -$25.0M | -$33.6M | -$39.5M | -$24.0M | -$15.8M |
| Share repurchases | $10.0M | — | — | $38.0M | $0 |
| Impairments | $0 | $63.8M | $49.6M | — | $0 |
Shares outstanding 50.4M · Free float 84.5%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.